Navigation Links
Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals
Date:6/12/2008

FT. LAUDERDALE, Fla., June 12 /PRNewswire-FirstCall/ -- Synovics Pharmaceuticals, Inc., (OTC Bulletin Board: SYVC) a specialty pharmaceutical company, announced today that on June 6, 2008, it formalized a strategic partnership with Maneesh Pharmaceuticals, LTD ("Maneesh") through the formation of a joint venture ("JV"). The JV between the companies is intended to be used as a vehicle for Synovics to have access to assets of Maneesh including personnel, drug development, operating and management systems and manufacturing. The terms of the JV provide that the Company will pay Maneesh a modest monthly fee beginning in six months and reimbursement for certain costs. There is no anticipated sharing or other distribution of Synovics' profits with Maneesh in the JV, although the parties may agree to certain fees for products or technology licensed in the future. The Company announced on May 15, 2008 that Maneesh had completed a second financing of $5 million bringing Maneesh's investment in the Company to a total of $12 million. In addition to the new capital, Maneesh assumed a guarantee that the Company has with the Bank of India in the amount of $6.55 million, allowing the Company to fully release the previous guarantors of Nirmal Mulye and Nostrum Pharmaceuticals, Inc. Maneesh has three representatives on Synovics' board of five directors.

"The strategic JV with Maneesh, together with the previously announced partnership with Harcharan ("Harry") Singh, represents a new beginning for Synovics. The Maneesh/Singh alliances completes our goal of establishing a foundation in India for our "Front-End" strategy -- a strategy of sourcing lowest cost, highly competitive generic drug products from India, marketed to our US customers through our Ft Lauderdale operations," stated Ronald Howard Lane, Ph.D., Synovics' Chairman and Chief Executive Officer. "Maneesh provides a critical high quality competitive manufacturing technology as a cornerstone of this strategy. In
'/>"/>

SOURCE Synovics Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...Nov. 27 Allrecipes.com , the wo...ing traffic numbers, with more than 2.8 million vi...ear picture of what was served on the biggest food...l in 2009 weighed in at 2,225 calories per serving...ording to the Allrecipes site, Sweet Potato Pie I...
(Date:11/27/2009)...nteractive anatomy education apps from Modality an...sciences learning opportunities for iPhone and iPo...us) November 27, 2009 -- Modality, Inc. and Lipp... Wolters Kluwer Health, today announced the availa...App Store. Clemente’s Anatomy, Rohen’s...
(Date:11/26/2009)...hiomolybdate (TM) has been shown in studies to be ...sease caused by an overload of copper, and certain...le, however, is known about how the drug works at ...estern University researchers now has provided an ...f TM bound to copper-loaded metallochaperones. The...
(Date:11/26/2009)...im of the Live Life Again Center, a practice offer...rowing number of physicians who are taking advant...with individuals who are interested in surgical we...im is utilizing Facebook to share before-and-after...e community. , Dallas, TX...
(Date:11/25/2009)...Newswire-USNewswire/ -- When most people hear the ...hiropractor can also give patients the help they n... which is where your jaw (mandible) contacts/conne...st common symptoms associated with TMJ dysfunction... jaw. But many other symptoms can be caused from ...
Breaking Medicine News(10 mins):Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3
...i Ramadoss on Tuesday said that the health sector ...ping nation . In his opening remarks at th...) of National Rural Health Mission (NRHM), Ramados...f the population from the health services have to ...
...e or lentils, for a new study has found that foods...hey have been consumed helps dieters lose more wei...vels. Foods that release sugars rapidly ar...Scientific Director of the Centre for Evidence Bas...
... early stage breast cancer was not reduced in wome...it and fiber and low in fat. This group of women w...or more servings a day of fruit and vegetables (th...eview of the literature found that a diet high in ...
... tumour necrosis factor alpha (TNF-alpha) is the ... The study was conducted by a team of researchers ...of Zurich, Switzerland. The protein was kn...gue. Cancer patients, for example, treated...
...eered by researchers from VIB and Ghent University...he British-American biotech company Acambis . ...n against all A strains of the virus that causes h...s Walter Fiers, invented a universal flu vaccine. ...
... confirm or deny reports about his girlfriend Nico...ew with radio host Kelly K, the Good Charlotte fro...o share the news with the world. The DJ be...s in store, Madden replied even before Kelly could...
Other Medicine News:Health News:Apples and Lentils Could Help You to Shed Off Those Extra Pounds! 2Health News:Breast Cancer Risk is not Reduced by a Diet Rich in Fruit and Vegetables 2Health News:Human Trial for Universal Influenza Vaccine Underway 2
(Date:11/25/2009).... 25 Praxis Electronic Medical Rec... Academy of Family Physicians, (AAFP) Family Pract...rvey for improving medical quality, health mainten... ARRA Stimulus legislation. Praxis also ranked #1 ...effect in determining their salary. Finally, Praxi...
(Date:11/25/2009)... ERT (Nasdaq: ERES ), a...ompany,s President and CEO, and Keith Schneck, the...cheduled to present at the 21st Annual Piper Jaffr...er 1, 2009 in New York City, New York. ,, Inter...ing the Company,s corporate website at http://www...
(Date:11/25/2009)...25 Remedium Technologie...foam that stops severe bleeding, won first prize a...egory of the Global Security Challenge 2009, compa...ore than 100 entries from around the world, Remedi...ity Summit conference held at the London School of...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Pelleve 28TM 29 Wrinkle Treatment System Featured On Beauty Spaces TV Show 5489 1Pelleve 28TM 29 Wrinkle Treatment System Featured On Beauty Spaces TV Show 5489 2National Long Term Care Leaders Praise Senator Snowes Recognition of Nursing Homes Unique Funding Challenges in Caring for Nations Seniors 5486 1National Long Term Care Leaders Praise Senator Snowes Recognition of Nursing Homes Unique Funding Challenges in Caring for Nations Seniors 5486 2Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast 5483 1
...apentadol Efficacy and Tolerability for Acute Pain...ted that up to 30 percent of all people who have s...uch as nausea and vomiting. The use of opioid pain...isk factor for experiencing these side effects. Na... and can have an impact on a patient,s recovery. ,...
...l to be Held at 9:00 a.m. Eastern Time Today, May ...herapeutics Corporation (Nasdaq: UTHR ) announce...istration (FDA) has approved ADCIRCA(TM) (tadalafi...nded dose of 40 mg, as the first once-daily phosph...ent of pulmonary arterial hypertension (PAH). ADC...
Other Medicine Technology:New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 2New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 4New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 5New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 6New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 8FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 2FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 3FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 4
Snap-In Snap-Out®-II Double Ring Handle, insulated handle and shaft
Snap-In Snap-Out®-II Single Ring Handle with Finger Tang, ratcheted, noninsulated handle, insulated shaft
Snap-In Snap-Out®-II Single Ring Handle, insulated handle and shaft
Insulated stainless steel nonlocking handle (with cautery)
Medicine Products: